Neuphoria Therapeutics Inc. (NEUP)
NASDAQ · Healthcare
Neuphoria Therapeutics Inc. EPS 2025–2025
Neuphoria Therapeutics Inc. annual/quarterly eps history and growth rate from 2025 to 2025. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Neuphoria Therapeutics Inc. eps for the quarter ending March 31, 2025 was $6.55.
- Neuphoria Therapeutics Inc. annual eps for 2025 was $0.23.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Neuphoria Therapeutics Inc. EPS — FAQ
Neuphoria Therapeutics Inc. (NEUP) eps over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
What is Neuphoria Therapeutics Inc.'s eps?
Neuphoria Therapeutics Inc. (NEUP) reported eps of $-0.23 for fiscal 2025.
Where can I see NEUP's eps history?
The chart and table above show Neuphoria Therapeutics Inc.'s eps by year and by quarter, including the growth rate.